Nanomedicine: An Alternative Approach Towards Anti-angiogenic Cancer Therapy

dc.contributor.author	Mukherjee S.; Madamsetty V.S.
dc.date.accessioned	2025-05-23T11:23:48Z
dc.description.abstract	The molecular mediators of angiogenesis consist of different growth factors and cytokines (e.g., VEGF and FGF), matrix metalloproteinases (MMPs), and molecules involved in intracellular signaling pathways (Rho GTPases) (Ucuzian et al in J Burn Care Res 31:158–175, 2010, [1]). © 2022, The Author(s), under exclusive license to Springer Nature Switzerland AG.
dc.identifier.doi	https://doi.org/10.1007/978-3-031-11284-3_3
dc.identifier.uri	http://172.23.0.11:4000/handle/123456789/9426
dc.relation.ispartofseries	Synthesis Lectures on Biomedical Engineering
dc.title	Nanomedicine: An Alternative Approach Towards Anti-angiogenic Cancer Therapy

Collections